)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
CareDx
CareDx (CDNA) investor relations material
CareDx Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary24 Feb, 2026
Executive summary
Achieved 25% year-over-year revenue growth in Q4 2025 and 14% for the full year, driven by expanded commercial presence, new product launches, and strong testing volume and pricing expansion.
Introduced innovative products such as AlloSure Heart for Pediatrics, AlloSure Plus, HistoMap Kidney, and advanced digital integrations, enhancing clinical adoption and differentiation.
Advanced infrastructure with automation, AI in revenue cycle management, and Epic Aura integration to streamline operations and improve efficiency.
Strengthened evidence base with multiple published studies, including SHORE and KOAR registries, supporting market leadership in transplant diagnostics.
Ended 2025 with $201 million in cash and no debt after $88 million in share repurchases.
Financial highlights
Q4 2025 revenue was $108.4 million (+25% YoY); full-year revenue reached $380 million (+14% YoY).
Q4 testing services revenue: $78.4 million (+23% YoY), with 53,000 tests performed (+17% YoY); average revenue per test was ~$1,480.
Q4 patient and digital solutions revenue: $17 million (+47% YoY); Q4 lab product revenue: $13 million (+17% YoY).
Q4 non-GAAP gross margin: 69%; full-year non-GAAP gross margin: 69%.
Q4 adjusted EBITDA: $6.5–$7 million (impacted by a one-time bonus); full-year adjusted EBITDA: $31.7–$32 million (+14% YoY).
Outlook and guidance
2026 revenue guidance: $420–$444 million (midpoint +14% YoY), including a $7.5 million headwind from Medicare LCD policy changes.
Testing services revenue expected at $306–$326 million; volume guidance is 220,000–228,000 tests (+12% YoY at midpoint); average revenue per test projected in the low $1,400s.
Patient and digital solutions plus lab products revenue expected at $114–$118 million (+8–12%).
Non-GAAP gross margin expected at 69–71%; adjusted EBITDA guidance is $30–$45 million.
Impact of 2024 litigation reversal on 2025 GAAP?
Quantify Q4 2025 EBITDA without equity comp.
Detail Medicare LCD impact on 2026 revenue guidance.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next CareDx earnings date
Q1 202629 Apr, 2026
CareDx
Next CareDx earnings date
Q1 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers UNITY HEART, a precision medicine platform to diagnose the degree of cardiac allograft rejection without the need for a confirmatory endomyocardial biopsy; and UNITY OV, an automated whole blood donor screening system to detect donor-derived cell-free DNA prior to solid organ transplantation and non-invasive as well as categorical monitoring of allograft injury. The company also provides AlloMap heart transplant test that measure mRNA transcripts from 22 genes expressed in immune cells and fibroblasts for personalized patient management; and AlloSure kidney transplant test to measure the amount of a donor specific DNA in a recipient’s bloodstream.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage